INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1%
Wed, 14 Aug

INDOCO REMEDIES has announced its results for the quarter ended June 2019. Here is a detailed performance review of the same:

INDOCO REMEDIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-18*
3
Mar-19*
3
Jun-19*
QoQ ChangeYoY Change
Net SalesRs m2,1752,5202,5270.3%16.2%
Other incomeRs m3496-87.0%106.5%
TurnoverRs m2,1782,5702,533-1.4%16.3%
ExpensesRs m2,0602,2352,2992.9%11.6%
Gross profitRs m116286228-20.3%96.6%
DepreciationRs m167195170-12.7%1.6%
InterestRs m72466132.2%-14.8%
Profit before taxRs m-120943-97.0%
TaxRs m0-22-190.0%
Profit after taxRs m-12011622-81.3%
Gross profit margin%5.311.39.0
Effective tax rate%0.0-23.7-678.6
Net profit margin%-5.54.50.9
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 16.2% on a year-on-year (YoY) basis. The expenses were up by 11.6% YoY during the same period.
  • The company's operating profit increased by 96.6% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 9.0% in 1QFY20 as against 5.3% in 1QFY19.
  • Depreciation charges increased by 1.6% and finance costs declined by 14.8% YoY, respectively.
  • Other income increased by 106.5% YoY during the quarter.
  • Net profit for the quarter increased by 118.1% YoY. Net profit margins during the quarter increased from -5.5% in 1QFY19 to 0.9% in 1QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 0.3% on a quarter-on-quarter (QoQ) basis. The expenses were up by 2.9% QoQ during the same period.
  • The company's operating profit declined by 20.3% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 9.0% in 1QFY20 as against 11.3% in 4QFY19.
  • Net profit for the quarter declined by 81.3% QoQ, while net profit margins declined from 4.5% in 4QFY19 to 0.9% in 1QFY20.

To see how INDOCO REMEDIES has performed over the last eight quarters,please visit here.

INDOCO REMEDIES Share Price Performance

Over the last one year,INDOCO REMEDIES share price has moved down from Rs 196.0 to Rs 154.6, registering a Loss of Rs 41.4 or around 21.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,484.3 (down 0.7%). Over the last one year it has moved down from 14,687.0 to 12,484.3, a gain of 2,203 points (down 15.0%).

Overall, the S&P BSE SENSEX is down 0.6% over the year.

Current Valuations

At the current price of Rs 154.6, the price to earnings (P/E) ratio of INDOCO REMEDIES stands at 125.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.1 times.

Equitymaster requests your view! Post a comment on "INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1%". Click here!

  

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (3QFY20); Net Profit Up 74.9% (Quarterly Result Update)

Jan 27, 2020 | Updated on Jan 27, 2020

For the quarter ended December 2019, INDOCO REMEDIES has posted a net profit of Rs 93 m (up 74.9% YoY). Sales on the other hand came in at Rs 3 bn (up 10.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Apr 16, 2021 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - NALWA SONS INV COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS